Poorer Quality of Life Outcomes Are Associated with Higher Levels of Stress, Lower Levels of Resilience, and Poorer Adjustment to Cancer in Outpatients Receiving Chemotherapy.
Jung Ae Kim, Astrid Block, Sueann Mark and 7 others
PMID 40940173WHAT IT FOUND
Among chemotherapy outpatients, 26.9% were in a low quality-of-life class; these patients had higher stress, lower resilience, poorer mental adjustment, depression, back pain, and lower function.
Use these cues to screen and refer.
Key findings
01Three QOL classes were identified: Low 26.9%, Moderate 44.7%, High 28.4%; scores remained relatively stable over time.
02Patients in the Low QOL class had higher stress, lower resilience, and poorer mental adjustment than other classes.
03The Low QOL class had lower functional status and more self-reported depression and back pain than the High class.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The quality-of-life follow-up lasted only two chemotherapy cycles, so persistence after treatment is unknown. Patients who declined participation were often overwhelmed by treatment, so the sample may underestimate distress and quality-of-life problems. The sample was relatively homogeneous in age, gender, education, and ethnicity, so findings may not generalize to more diverse groups. The study compared groups and did not test whether stress, resilience, or mental adjustment caused quality-of-life differences. No intervention was tested, so the paper does not show that physical therapy, mindfulness, or referral improves quality of life.
Declared interests
The study was part of a larger National Cancer Institute-funded project. The authors declared no conflicts of interest.
The easy way to misread this
Do not conclude that reducing stress or increasing resilience will improve quality of life. This study compared groups and followed patients for only two chemotherapy cycles, so it did not test any treatment.